Results
24
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
24 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €5.66 | -2.7% | -37.5% | €85.1m | €6.30 | PS14.1x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €11.94 | -0.5% | -38.6% | €98.6m | €20.75 | PE13.1x | E36.0% | n/a | Capital Goods | ||
VU | €150.50 | 6.3% | 22.8% | €2.4b | €194.50 | PS2.9x | E82.3% | 0.2% | Tech | ||
FDE | €28.75 | 6.5% | -33.1% | €151.8m | €60.33 | PE19.3x | E31.9% | n/a | Energy | ||
ALMUN | €0.41 | -0.2% | -80.3% | €3.6m | €1.30 | PB0.3x | E149.1% | n/a | Tech | ||
OSE | €6.58 | -27.9% | 26.5% | €143.1m | €13.50 | PS64.3x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
ALCUR | €6.48 | 8.4% | 166.7% | €37.4m | €8.48 | PE20.7x | E27.5% | n/a | Capital Goods | ||
ALICA | €9.82 | -1.4% | -28.3% | €79.4m | €15.00 | PE14.5x | E28.1% | 2.0% | Tech | ||
MEDCL | €16.40 | -2.4% | 151.9% | €477.0m | €22.03 | PS39.9x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
ALSTI | €18.40 | 3.7% | n/a | €93.6m | €16.50 | PE46.8x | E28.5% | 1.0% | Capital Goods | ||
ALSMA | €3.96 | -2.9% | 53.5% | €20.7m | €5.80 | PE19.5x | E35.2% | n/a | Healthcare | ||
ALLIX | €8.76 | -4.2% | -11.5% | €57.5m | €13.50 | PS1.7x | E102.1% | n/a | Software | ||
ALECP | €0.52 | -6.4% | -20.6% | €64.5m | n/a | PE71.6x | E86.8% | 0% | Media | ||
ALVGO | €3.06 | -1.3% | -20.9% | €18.6m | €4.40 | PS1.5x | E77.2% | n/a | Software | ||
ALHOP | €22.30 | -1.3% | 39.8% | €64.0m | €30.40 | PE14x | E22.3% | 2.9% | Media | ||
ALCIS | €8.16 | -1.4% | -8.9% | €63.5m | €12.10 | PE19.9x | E56.5% | 2.0% | Commercial Services | ||
LSS | €28.80 | 1.8% | 9.5% | €1.1b | €34.58 | PE34.2x | E29.3% | 1.3% | Software | ||
OVH | €6.15 | 3.3% | -31.1% | €1.2b | €9.35 | PS1.2x | E101.1% | n/a | Software | ||
GUI | €5.10 | -4.9% | -23.0% | €76.7m | €7.85 | PE79.5x | E55.0% | 0% | Tech | ||
CLA | €1.30 | -9.2% | -19.8% | €73.9m | €4.65 | PE-14.8x | E88.7% | n/a | Software | ||
S30 | €1.50 | -0.3% | -42.3% | €160.3m | €2.17 | PB1.5x | E100.6% | n/a | Software | ||
ALPAT | €14.90 | -4.5% | 25.2% | €16.5m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
ALBLD | €15.35 | -0.6% | -2.8% | €69.8m | €21.43 | PE24.9x | E30.5% | n/a | Media | ||
EXN | €23.50 | 0.2% | 31.1% | €2.1b | €25.33 | PE51.9x | E33.7% | 0% | Software |